Lemonex Inc.
PrivateLast Round
Grant
Jan 4, 2024
Est. Valuation
$196.69M
Total Funding Raised
$31.98M
Company Overview
Lemonex Inc. operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Grant round in January 2024.
Lemonex Inc. is a biotechnology company that develops drug delivery technology for cancer immunotherapeutics, antibody therapeutics, and gene therapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lemonex Inc. Comparables
Compare Lemonex Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Acuitas Therapeutics | 77% | |
| Genevant Sciences | 77% | |
| EnhancedBio | 76% |
For institutional investors. Book with your work email.
Lemonex Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 4, 2024 | ||||
| IPO | Jul 11, 2023 | ||||
| Series C | Apr 21, 2021 | ||||
| Series B | Dec 6, 2018 | ||||
| Series A | Mar 12, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Lemonex Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DA Value Investment | Series B |
| KDB Capital Corp | Series B |
| Smilegate Investment | Series C |
| CEPI | Grant |
| TS Investment | Series B |
| Samsung Securities Co., Ltd. | IPO |
| Daegyeong Investment | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors increased 80% MoM.
- Jan 2, 2026
Monthly visitors increased 65% MoM.
For institutional investors. Book with your work email.
Lemonex Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Lemonex Inc.'s valuation, stock price, and market status.
Is Lemonex Inc. a public or private company?
Lemonex Inc. is a private company.
What is the current stock price of Lemonex Inc.?
Lemonex Inc. is a private company, so its shares have no public market price. Caplight tracks Lemonex Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Lemonex Inc. worth (valuation)?
Lemonex Inc.'s valuation is estimated at $196.7M based on funding round data.
Can I buy Lemonex Inc. stock?
Lemonex Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Lemonex Inc.'s last funding round?
Lemonex Inc.'s most recent funding round was Grant on January 4, 2024.
Who are the main investors in Lemonex Inc.?
Key investors in Lemonex Inc. include Samsung Securities Co., Ltd., Union Investment Partners.
Will Lemonex Inc. IPO soon?
No public IPO plans have been announced for Lemonex Inc..
How can I track Lemonex Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Lemonex Inc.'s shares on secondary markets.